Glenmark Pharmaceuticals Inc., USA Recall: Atomoxetine Capsules, USP, 80 mg, 30 capsule bo
Glenmark Pharmaceuticals Inc., USA Recall: Atomoxetine Capsules, USP, 80 mg, 30 capsule bo is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Glenmark Pharmaceuticals Inc., USA; Product: Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceutic
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
|---|---|
| Product | Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-270-30. |
| Reason for recall | CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | Nationwide within the U.S |
| Recall initiated | 20250129 |
| Recall number | D-0236-2025 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →